These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6277657)

  • 1. Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1982 Jan; 77(1):79-83. PubMed ID: 6277657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
    Barrett RJ; Lokhandwala MF
    Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pergolide, a dopamine receptor agonist, and clonidine on cardiovascular responses evoked by activation of peripheral sympathetic outflow in rats.
    Cavero I
    Clin Exp Hypertens A; 1982; 4(1-2):221-33. PubMed ID: 7074987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
    Lokhandwala MF; Kivlighn SD; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of peripheral dopamine receptor and alpha-adrenoceptor blocking activity of sulpiride.
    Barrett RJ; Ginos JZ; Lokhandwala MF
    Eur J Pharmacol; 1982 Apr; 79(3-4):273-81. PubMed ID: 6124431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of central dopamine receptors in the hypotensive action of pergolide.
    Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine on sympathetic neurotransmission to the myocardium.
    Martinez AA; Lokhandwala MF
    Eur J Pharmacol; 1980 May; 63(4):303-11. PubMed ID: 6248349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF; Steenberg ML
    J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cardiac sympathetic neurotransmission by adenosine.
    Lokhandwala MF
    Eur J Pharmacol; 1979 Dec; 60(4):353-7. PubMed ID: 230983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat.
    Dupont AG; Lefebvre RA; Bogaert MG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):146-51. PubMed ID: 4010793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart.
    Dlewati A; Watkins HO; Lokhandwala MF
    Eur J Pharmacol; 1989 May; 164(2):197-203. PubMed ID: 2569408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversal by metoclopramide of apomorphine-induced inhibition of responses to stimulation of the cardioaccelerator nerves in the cat.
    Tuncer M
    Indian J Physiol Pharmacol; 1984; 28(1):15-20. PubMed ID: 6490125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro dopaminergic effects of three ergoline fragments.
    Koons JC; Long JP; Cannon JG
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):180-5. PubMed ID: 6527705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.
    Fuller RW; Hemrick-Luecke SK; Perry KW; Toomey RE
    J Pharm Pharmacol; 1985 Apr; 37(4):268-70. PubMed ID: 2860228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of presynaptic inhibitory alpha 1-adrenoceptors in the cardiac sympathetic nerves of the dog: effects of prazosin and yohimbine on sympathetic neurotransmission to the heart.
    Uchida W; Kimura T; Satoh S
    Eur J Pharmacol; 1984 Aug; 103(1-2):51-6. PubMed ID: 6090178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by partial ergoline.
    Rabey JM; Passeltiner P; Markey K; Asano T; Goldstein M
    Brain Res; 1981 Nov; 225(2):347-56. PubMed ID: 6118195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile.
    Barrett RJ; Lokhandwala MF
    J Pharmacol Exp Ther; 1981 Jun; 217(3):660-5. PubMed ID: 6112262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.